皮脂腺痣相关良性与恶性继发肿瘤发生率:系统综述与Meta分析
该系统综述与Meta分析检索PubMed、Embase和Web of Science至2023年4月,纳入28项研究、其中22项进入Meta分析,估计皮脂腺痣继发肿瘤总发生率为12.8%(95%CI 9.2%-17.6%),恶性与良性肿瘤发生率分别为2.4%(95%CI 1.4%-4.1%)和10.3%(95%CI 7.5%-13.9%)。作者认为尽管恶变率低但不可忽视,儿童期切除仍是合理的一线选择,但可能遗留不美观瘢痕。
要点
- 皮脂腺痣继发肿瘤总发生率为12.8%(95%CI 9.2%-17.6%)。
- 恶性与良性继发肿瘤发生率分别为2.4%(95%CI 1.4%-4.1%)和10.3%(95%CI 7.5%-13.9%)。
- 基底细胞癌发生率1.7%(95%CI 0.9%-3.2%),乳头状汗管囊腺瘤3.6%(95%CI 2.5%-5.3%),毛母细胞瘤2.6%(95%CI 1.7%-3.8%)。
核心结论
- 皮脂腺痣原发皮损内恶性肿瘤发生率虽低但不可忽视;作者提出儿童期切除皮脂腺痣病变在合适患者中仍是合理的一线选择,但可能遗留不美观的瘢痕。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase和Web of Science自建库至2023年4月,纳入报告皮脂腺痣患者继发肿瘤发生率或风险的研究,样本量大于50例的研究进入随机效应模型Meta分析;共识别28项研究,其中22项符合Meta分析条件。
主要发现
- 继发肿瘤总体发生率为12.8%(95%CI 9.2%-17.6%)。
- 恶性肿瘤发生率为2.4%(95%CI 1.4%-4.1%),良性肿瘤发生率为10.3%(95%CI 7.5%-13.9%)。
- 基底细胞癌发生率为1.7%(95%CI 0.9%-3.2%)。
- 乳头状汗管囊腺瘤发生率为3.6%(95%CI 2.5%-5.3%),毛母细胞瘤发生率为2.6%(95%CI 1.7%-3.8%)。
临床怎么用
- 作者提出,在合适患者中儿童期切除皮脂腺痣病变仍是合理的一线选择,可预防继发恶性肿瘤、处理美容与功能并发症并避免未来复杂重建,但需注意可能遗留不美观的瘢痕。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nevus sebaceous (NS) is a rare congenital skin lesion affecting approximately 0.3% of all newborns. Although benign, NS lesions can harbor malignant secondary tumors. The published rate of development of these malignant tumors varies. This meta-analysis aimed to identify the rate of malignant and benign secondary neoplasms occurring in NS. METHODS: A literature search was conducted using PubMed, Embase, and Web of Science from inception to April 2023. Eligible studies reported incidence or risk of secondary neoplasms in patients with NS. Two independent reviewers screened studies, extracted data, and assessed the quality of included studies. The primary outcome was the pooled incidence of secondary neoplasms. Studies with sample sizes greater than 50 patients were eligible for meta-analysis using the random-effects model. RESULTS: Twenty-eight studies were identified, 22 of which were eligible for meta-analysis. The overall rate of secondary neoplasms was 12.8% (95% confidence interval [Cl], 9.2%-17.6%). The rates of development of malignant and benign tumors were 2.4% (95% CI, 1.4%-4.1%) and 10.3% (95% CI, 7.5%-13.9%), respectively. The rate of development of basal cell carcinoma was 1.7% (95% CI, 0.9%-3.2%), whereas the rate of the development of syringocystadenoma papilliferum was 3.6% (95% CI, 2.5%-5.3%) and that if trichoblastoma was 2.6% (95% CI, 1.7%-3.8%). CONCLUSIONS: Although the rate of development of malignant tumors within a primary NS lesion is low, it is not negligible. Prophylactic early excision remains a viable approach to prevent secondary malignant neoplasms, address cosmetic and functional complications, and preempt the need for complex reconstruction in the future. We propose that resection of NS lesions in childhood remains a reasonable first-line option in the appropriate patient keeping in mind that it may leave an undesirable scar.
引用
- Pang S, Cevik J, Sreedharan S, et al. Rate of Benign and Malignant Secondary Tumors Associated With Nevus Sebaceous: A Systematic Review and Meta-Analysis. Ann Plast Surg. 2024. PMID: 38725109. doi:10.1097/SAP.0000000000003879
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。